The most exciting aspect is miR449 and miR34 each repress E2F, but promote p53 activity, allowing efficient cross-talk between two major DNA damage-responsive gene regulators, which may thus represent a determinant for therapeutic manipulation in the treatment of cancer by irradiation or chemotherapy [21]. This evidence concerns the gene TP53 and cancer.